Ascertainment bias in the clinical diagnosis of Alzheimer disease

阿尔茨海默病临床诊断中的确定性偏倚

阅读:1

Abstract

BACKGROUND: The clinical diagnosis of Alzheimer disease (AD) is often based, at least in part, on poor cognitive test performance compared with normative values. OBJECTIVE: To examine the presence and extent of an ascertainment bias (omission of affected individuals) produced by such criteria when applied as early as possible in the course of the disease. DESIGN: Longitudinal study (1979-2008). SETTING: Washington University Alzheimer Disease Research Center, St Louis, Missouri. PARTICIPANTS: Of 78 individuals aged 65 to 101 years enrolled as healthy controls, 55 later developed autopsy-confirmed AD; 23 remained cognitively healthy and did not have neuropathologic AD. MAIN OUTCOME MEASURES: Criteria for the diagnosis of AD based on various cutoff points (1.5, 1.0, and 0.5 SDs below the mean for robust test norms) for 2 standard psychometric measures from each of 3 cognitive domains (episodic memory, visuospatial ability, and working memory) were applied to data from the first assessment associated with an independent clinical diagnosis of cognitive impairment for those who developed symptomatic AD and from the last assessment for those who did not. RESULTS: Areas under the curve from receiver operating characteristic analyses ranged from 0.71 to 0.49; sensitivities and specificities were unsatisfactory even after adjusting for age and education, using combinations of tests, or examining longitudinal decline before clinical diagnosis. CONCLUSION: Reliance on divergence from group normative values to determine initial cognitive decline caused by AD results in failure to include people in the initial symptomatic stage of the illness.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。